Production (Stage)
bluebird bio, Inc.
BLUE
$4.97
-$0.01-0.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 33.48% | -13.59% | -367.60% | -515.00% | -236.82% |
| Total Depreciation and Amortization | 62.12% | 114.70% | 131.68% | 164.70% | 180.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.29% | 2,655.29% | 167.76% | 174.26% | 170.62% |
| Change in Net Operating Assets | -146.66% | -161.55% | -11.91% | 30.19% | 14.67% |
| Cash from Operations | 4.02% | -10.63% | -31.70% | -7.78% | 9.12% |
| Capital Expenditure | 70.64% | 37.96% | -7.95% | -120.27% | 24.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -88.01% | -95.92% | -96.68% | -65.79% | -71.18% |
| Cash from Investing | -89.39% | -97.48% | -97.95% | -67.86% | -72.53% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -49.70% | -58.09% | -8.58% | -14.21% | -17.85% |
| Issuance of Common Stock | -- | -- | -9.51% | -33.20% | -36.10% |
| Repurchase of Common Stock | -- | -- | -- | 94.56% | -48.93% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 686.88% | 4,124.37% | 332,125.00% | 239,462.50% | 112,125.00% |
| Cash from Financing | -66.01% | -55.43% | 201.12% | 38.15% | 9.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -737.56% | -245.20% | -193.39% | -127.28% | -115.40% |